136 related articles for article (PubMed ID: 9434285)
1. Activation of the mononuclear phagocyte system by poloxamine 908: its implications for targeted drug delivery.
Armstrong TI; Moghimi SM; Davis SS; Illum L
Pharm Res; 1997 Nov; 14(11):1629-33. PubMed ID: 9434285
[TBL] [Abstract][Full Text] [Related]
2. A single dose of intravenously injected poloxamine-coated long-circulating particles triggers macrophage clearance of subsequent doses in rats.
Moghimi SM; Gray T
Clin Sci (Lond); 1997 Oct; 93(4):371-9. PubMed ID: 9404230
[TBL] [Abstract][Full Text] [Related]
3. Re-establishing the long circulatory behaviour of poloxamine-coated particles after repeated intravenous administration: applications in cancer drug delivery and imaging.
Moghimi SM
Biochim Biophys Acta; 1999 Oct; 1472(1-2):399-403. PubMed ID: 10572962
[TBL] [Abstract][Full Text] [Related]
4. Coating particles with a block co-polymer (poloxamine-908) suppresses opsonization but permits the activity of dysopsonins in the serum.
Moghimi SM; Muir IS; Illum L; Davis SS; Kolb-Bachofen V
Biochim Biophys Acta; 1993 Nov; 1179(2):157-65. PubMed ID: 8218358
[TBL] [Abstract][Full Text] [Related]
5. An investigation of the filtration capacity and the fate of large filtered sterically-stabilized microspheres in rat spleen.
Moghimi SM; Hedeman H; Muir IS; Illum L; Davis SS
Biochim Biophys Acta; 1993 Jul; 1157(3):233-40. PubMed ID: 8323953
[TBL] [Abstract][Full Text] [Related]
6. Prolonging the circulation time and modifying the body distribution of intravenously injected polystyrene nanospheres by prior intravenous administration of poloxamine-908. A 'hepatic-blockade' event or manipulation of nanosphere surface in vivo?
Moghimi SM
Biochim Biophys Acta; 1997 Jul; 1336(1):1-6. PubMed ID: 9271243
[TBL] [Abstract][Full Text] [Related]
7. Enhanced hepatic clearance of intravenously administered sterically stabilized microspheres in zymosan-stimulated rats.
Moghimi SM; Hedeman H; Christy NM; Illum L; Davis SS
J Leukoc Biol; 1993 Dec; 54(6):513-7. PubMed ID: 8245702
[TBL] [Abstract][Full Text] [Related]
8. Effect of splenic congestion associated with haemolytic anaemia on filtration of 'spleen-homing' microspheres.
Moghimi SM; Hedeman H; Illum L; Davis SS
Clin Sci (Lond); 1993 Jun; 84(6):605-9. PubMed ID: 8334806
[TBL] [Abstract][Full Text] [Related]
9. Real-time evidence of surface modification at polystyrene lattices by poloxamine 908 in the presence of serum: in vivo conversion of macrophage-prone nanoparticles to stealth entities by poloxamine 908.
Moghimi SM; Pavey KD; Hunter AC
FEBS Lett; 2003 Jul; 547(1-3):177-82. PubMed ID: 12860409
[TBL] [Abstract][Full Text] [Related]
10. Modification of the copolymers poloxamer 407 and poloxamine 908 can affect the physical and biological properties of surface modified nanospheres.
Neal JC; Stolnik S; Garnett MC; Davis SS; Illum L
Pharm Res; 1998 Feb; 15(2):318-24. PubMed ID: 9523321
[TBL] [Abstract][Full Text] [Related]
11. Concentration dependent structural ordering of poloxamine 908 on polystyrene nanoparticles and their modulatory role on complement consumption.
Al-Hanbali O; Rutt KJ; Sarker DK; Hunter AC; Moghimi SM
J Nanosci Nanotechnol; 2006; 6(9-10):3126-33. PubMed ID: 17048527
[TBL] [Abstract][Full Text] [Related]
12. Long circulating biodegradable poly(phosphazene) nanoparticles surface modified with poly(phosphazene)-poly(ethylene oxide) copolymer.
Vandorpe J; Schacht E; Dunn S; Hawley A; Stolnik S; Davis SS; Garnett MC; Davies MC; Illum L
Biomaterials; 1997 Sep; 18(17):1147-52. PubMed ID: 9259511
[TBL] [Abstract][Full Text] [Related]
13. Phagocytic uptake and cytotoxicity of solid lipid nanoparticles (SLN) sterically stabilized with poloxamine 908 and poloxamer 407.
Müller RH; Maassen S; Weyhers H; Mehnert W
J Drug Target; 1996; 4(3):161-70. PubMed ID: 8959488
[TBL] [Abstract][Full Text] [Related]
14. Polystyrene-poly (ethylene glycol) (PS-PEG2000) particles as model systems for site specific drug delivery. 2. The effect of PEG surface density on the in vitro cell interaction and in vivo biodistribution.
Dunn SE; Brindley A; Davis SS; Davies MC; Illum L
Pharm Res; 1994 Jul; 11(7):1016-22. PubMed ID: 7937542
[TBL] [Abstract][Full Text] [Related]
15. Recognition and clearance of methoxypoly(ethyleneglycol)2000-grafted liposomes by macrophages with enhanced phagocytic capacity. Implications in experimental and clinical oncology.
Laverman P; Carstens MG; Storm G; Moghimi SM
Biochim Biophys Acta; 2001 Jun; 1526(3):227-9. PubMed ID: 11410330
[TBL] [Abstract][Full Text] [Related]
16. The organ distribution and circulation time of intravenously injected colloidal carriers sterically stabilized with a block copolymer--poloxamine 908.
Illum L; Davis SS; Müller RH; Mak E; West P
Life Sci; 1987 Jan; 40(4):367-74. PubMed ID: 3807638
[TBL] [Abstract][Full Text] [Related]
17. A noticeable phenomenon: thiol terminal PEG enhances the immunogenicity of PEGylated emulsions injected intravenously or subcutaneously into rats.
Wang C; Cheng X; Sui Y; Luo X; Jiang G; Wang Y; Huang Z; She Z; Deng Y
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):744-51. PubMed ID: 24129310
[TBL] [Abstract][Full Text] [Related]
18. Influence of the surfactant concentration on the body distribution of nanoparticles.
Araujo L; Löbenberg R; Kreuter J
J Drug Target; 1999; 6(5):373-85. PubMed ID: 10342385
[TBL] [Abstract][Full Text] [Related]
19. Influence of the surface properties of low contact angle surfactants on the body distribution of 14C-poly(methyl methacrylate) nanoparticles.
Tröster SD; Kreuter J
J Microencapsul; 1992; 9(1):19-28. PubMed ID: 1613640
[TBL] [Abstract][Full Text] [Related]
20. Humoral-mediated recognition of 'phagocyte-resistant' beads by lymph node macrophages of poloxamine-treated rats.
Moghimi SM
Clin Sci (Lond); 1998 Sep; 95(3):389-91. PubMed ID: 9890787
[No Abstract] [Full Text] [Related]
[Next] [New Search]
